A recent case in Scotland's Court of Session addressed this very topic. The decison is published here and is quite lengthy but a good read, especially if you having toruble sleeping! If you are the sort of person who reads the last page of a book first go to paragraph 81.
|
Proposals for a new EU directive on animal experimentation is dissected in The Guardian.
|
Micheal J Fox believes an Obama administratioon will lift the restrictions on federal spending on stem cell research imposed by the outgoing Bush administration. More here.
|
Alnylam Pharmaceuticals announced today that it has published new research with collaborators at Mayo Clinic in the journal Molecular Neurodegeneration. The new pre-clinical findings demonstrate durable therapeutic silencing of the alpha-synuclein gene in mice. Alpha-synuclein is believed to play a central role in the development of Parkinson's disease, where the accumulation of excess alpha-synuclein protein has been associated with the cause and/or pathway of the disease. More here.
|
A new scheme to raise awareness of PD. Read it here.
|
A critical turning point is coming for Ceregene by the end of the year. The San Diego-based biotech company expects to get results in the next couple months on whether its experimental gene therapy can effectively help treat Parkinson’s disease. More here.
|
Researchers in Scotland are moving closer to developing treatments for Parkinson's disease using stem cells, a conference will hear this week. The MRC Centre for Regenerative Medicine at Edinburgh University has been turning embryonic stem cells into a cell type lost in Parkinson's patients. Dr Tilo Kunath, who has been working on the project, said the ultimate aim was to create enough appropriate cells to inject into the brains of patients to reverse the effects of the neurological condition. Dr Kunath will tell the conference in York about the steps his team has taken towards creating the vital cells in their lab. Dr Kunath told The Scotsman he was confident a cure would be found.
|
The Swedish Masseur explains the advantages of being a contortionist.
|
Not me. Ryan Reynolds. My turn comes this day next year.
|
Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and ALS, disrupt the quality of life for patients, put a tremendous burden on family caregivers, and cost society billions of dollars annually. A commonality shared among this diverse set of disorders is the progressive and relentless loss of certain populations of neurons. In the November issue of EBM, researchers have identified a class of compounds, 3-substituted indolones, that can protect neurons from degeneration.. More here.
|